Grant: Engage Grants Program
Dalhousie University
$24,945.00
Membrane Optimization for Anesthesia CO2 Separation Device
EF 2012-13
Résumé
DMF Medical Inc., a Nova Scotia based corporation, has developed a new, membrane based CO2 removal
device for anesthesia circuits called ZeroSorb. A CO2 removal device is mandatory for two thirds of all
operations performed under general anesthesia. The new device operates in a manner similar to existing CO2
removal devices except that, unlike existing devices, it does not react to create toxic by-products when
contacted with anesthetic gases. These toxic by-products are inhaled by patients undergoing anesthesia and are
linked to a condition known as Post Operative Decline (POCD).
This project will investigate and optimize the design of the ZeroSorb device for its ability to to perform
industry-leading, safe, CO2 removal in anesthesia circuits. During the project, alternative configurations of the
device will be investigated to arrive at an optimal design. DMF Medical Inc. will then produce prototype
quantities of the device for testing in clinical trials and acquiring regulatory approval. The product will then be
commercialized for sale world-wide.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
434531-2012
Name nom
Haelssig, Jan
Department département
Process Engineering and Applied Science
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
24945
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Membrane Optimization for Anesthesia CO2 Separation Device
Keyword
NSERC
Application summary
DMF Medical Inc., a Nova Scotia based corporation, has developed a new, membrane based CO2 removal
device for anesthesia circuits called ZeroSorb. A CO2 removal device is mandatory for two thirds of all
operations performed under general anesthesia. The new device operates in a manner similar to existing CO2
removal devices except that, unlike existing devices, it does not react to create toxic by-products when
contacted with anesthetic gases. These toxic by-products are inhaled by patients undergoing anesthesia and are
linked to a condition known as Post Operative Decline (POCD).
This project will investigate and optimize the design of the ZeroSorb device for its ability to to perform
industry-leading, safe, CO2 removal in anesthesia circuits. During the project, alternative configurations of the
device will be investigated to arrive at an optimal design. DMF Medical Inc. will then produce prototype
quantities of the device for testing in clinical trials and acquiring regulatory approval. The product will then be
commercialized for sale world-wide.